UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000050512
Receipt number R000057461
Scientific Title The clinical trial evaluating the usefulness of Linked Color Imaging(LCI) in surveillance colonoscopy of ulcerative colitis.
Date of disclosure of the study information 2023/05/01
Last modified on 2024/09/05 19:13:52

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The clinical trial evaluating the usefulness of Linked Color Imaging(LCI) in surveillance colonoscopy of ulcerative colitis.

Acronym

UC/LCI test

Scientific Title

The clinical trial evaluating the usefulness of Linked Color Imaging(LCI) in surveillance colonoscopy of ulcerative colitis.

Scientific Title:Acronym

UC/LCI test

Region

Japan


Condition

Condition

Ulcerqative colitis

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to demonstrate the non-inferiority of chromo-endoscopy and Linked Color Imaging (LCI) in the detection rate of ulcerative colitis associated neoplasia (UCAN) in surveillance colonoscopy for patients with ulcerative colitis. If LCI is equal to or better than chromo-endoscopy in detecting UCAN, it will reduce the time required for surveillance endoscopy, improve complexity by eliminating dye spraying, and reduce the burden on both the patient and the endoscopist during the examination. If LCI significantly improves UCAN detection, it would be a novel finding as the most effective surveillance method.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

detection rate

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Diagnosis

Type of intervention

Maneuver

Interventions/Control_1

Observation after spraying indigocarmine over the entire colon during surveillance colonoscopy for patients with ulcerative colitis who have given consent.

Interventions/Control_2

Observation using LCI during surveillance colonoscopy for patients with ulcerative colitis who have given consent.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with disease duration of more than 6 years
Patients with total or left-sided colitis
Patients who have not undergone surveillance colonoscopy in the past 6 months
Patients with a Partial Mayo score of 4 or less
Patients who understand the study and have given written consent

Key exclusion criteria

Patients with severe acute inflammation on endoscopic findings
Pregnant patients
Patients with extremely poor general condition, intestinal perforation, pancreatitis, respiratory disease, circulatory disease, acquired hemophilia, stenosis, large ulcer or tumor, or other conditions in which the risk of performing endoscopy exceeds the benefit
Patients with serious functional impairment of the heart, lungs, kidneys, or liver
Patients with bradycardia or atrioventricular block
Patients who are incapable of self-judgment
Patients with Poor and Inadequate cleanliness (Aronchick score)
Patients deemed inappropriate by the physician in charge.

Target sample size

600


Research contact person

Name of lead principal investigator

1st name Takeshi
Middle name
Last name Yamamura

Organization

Nagoya University Hospital

Division name

Department of Gastroenterology and Hepatology

Zip code

4668560

Address

65 Tsurumai, Showa-ku, Nagoya City ,Aichi Prefecture

TEL

0527442172

Email

tyamamu@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name Keisuke
Middle name
Last name Oiwa

Organization

Nagoya University Hospital

Division name

Department of Gastroenterology and Hepatology

Zip code

4668560

Address

65 Tsurumai, Showa-ku, Nagoya City ,Aichi Prefecture

TEL

0527442172

Homepage URL


Email

k-oiwa@med.nagoya-u.ac.jp


Sponsor or person

Institute

Nagoya University

Institute

Department

Personal name



Funding Source

Organization

nothing

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagoya University Hospital Office of Medical Research and Clinical Ethics

Address

65 Tsurumai, Showa-ku, Nagoya City ,Aichi Prefecture

Tel

0527412111

Email

ethics@med.nagoya-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2023 Year 07 Month 01 Day

Last follow-up date

2026 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 03 Month 06 Day

Last modified on

2024 Year 09 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057461